Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes

Neurology

Volumn 60, Issue 11, 2003, Pages 1761-1766

  Powers, K M ^a   Smith Weller, T ^a   Franklin, G M ^a   Longstreth Jr , W T ^a   Swanson, P D ^a   Checkoway, Harvey ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; FAT; IRON; MANGANESE;

ADULT; AGED; ARTICLE; CALCULATION; CALORIC INTAKE; CASE CONTROL STUDY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIETARY INTAKE; DISEASE ASSOCIATION; FAT INTAKE; FEMALE; FOOD INTAKE; HABIT; HEALTH MAINTENANCE ORGANIZATION; HUMAN; INTERVIEW; IRON INTAKE; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

EID: 0038454676     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000068021.13945.7F     Document Type: Article

References (36)

1. Langston JW. Epidemiology versus genetics in Parkinson's disease: progress in resolving an age-old debate. Ann Neurol 1998;44:S45-S52.
2. Johnson CC, Gorell JM, Rybicki BA, Sanders K, Peterson EL. Adult nutrient intake as a risk factor for Parkinson's disease. Int J Epidemiol 1999;28:1102-1109.
3. Anderson C, Checkoway H, Franklin GM, Beresford S, Smith-Weller T, Swanson PD. Dietary factors in Parkinson's disease: the role of food groups and specific foods. Mov Disord 1999;14:21-27.
4. Logroscino G, Marder K, Graziano J, et al. Dietary iron, animal fats, and risk of Parkinson's disease. Mov Disord 1998;13:13-16.
5. Schneider WL, Hershey JE, Vena JE, Holmlund T, Marshall JR, Freudenheim JL. Dietary antioxidants and other dietary factors in the etiology of Parkinson's disease. Mov Disord 1997;12:190-196.
6. de Rijk MC, Breteler MM, den Breeijen JH, et al. Dietary antioxidants and Parkinson disease. The Rotterdam Study. Arch Neurol 1997;54:762-765.
7. Hellenbrand W, Seidler A, Boeing H, et al. Diet and Parkinson's disease I: a possible role for the past intake of specific foods and food groups. Neurology 1996;47:636-643.
8. Hellenbrand W, Boeing H, Robra BP, et al. Diet and Parkinson's disease II: a possible role for the past intake of specific nutrients. Neurology 1996;47:644-650.
9. Logroscino G, Marder K, Cote L, Tang M, Shea S, Mayeux R. Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control study. Ann Neurol 1996;39:89-94.
10. Morens DM, Grandinetti A, Waslien CI, Park CB, Ross GW, White LR. Case-control study of idiopathic Parkinson's disease and dietary vitamin E intake. Neurology 1996;46:1270-1274.
11. Golbe LI, Farrell TM, Davis PH. Follow-up study of early-life protective and risk factors in Parkinson's disease. Mov Disord 1990;5:66-70.
12. Golbe LI, Farrell TM, Davis PH. Case-control study of early life factors in Parkinson's disease. Arch Neurol 1988;45:1350-1353.
13. Zhang SM, Hernan MA, Chen H, Spiegelman D, Willett WC, Ascherio A. Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk. Neurology 2002;59:1161-1169.
14. Gorell JM, Rybicki BA, Johnson CC, Peterson EL. Occupational metal exposures and the risk of Parkinson's disease. Neuroepidemiology 1999;18:303-308.
15. Gorell JM, Johnson CC, Rybicki BA, et al. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. Neurotoxicology 1999;20:239-247.
16. Gorell JM, Johnson CC, Rybicki BA, et al. Occupational exposures to metals as risk factors for Parkinson's disease. Neurology 1997;48:650-658.
17. Willet WC. Nutritional epidemiology. New York: Oxford University Press, 1990.
18. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state:" a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
19. Chua AC, Morgan EH. Effects of iron deficiency and iron overload on manganese uptake and deposition in the brain and other organs of the rat. Biol Trace Elem Res 1996;55:39-54.
20. Sorond FA, Ratan RR. Ironing-out mechanisms of neuronal injury under hypoxic-ischemic conditions and potential role of iron chelators as neuroprotective agents. Antioxid Redox Signal 2000;2:421-436.
21. Yantiri F, Andersen JK. The role of iron in Parkinson disease and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. IUBMB Life 1999;48:139-141.
22. Olanow CW, Tatton WG. Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 1999;22:123-144.
23. Bharath S, Hsu M, Kaur D, Rajagopalan S, Anderson JK. Glutathione, iron and Parkinson's disease. Biochem Pharmacol 2002;64:1037-1048.
24. Gerlach M, Ben-Schachar D, Riederer P, Youdim MBH. Altered brain metabolism of iron as a cause of neurogenerative diseases? J Neurochem 1994;63:793-807.
25. Racette BA, McGee-Minnich L, Moerlein SM, et al. Welding-related parkinsonism: clinical features, treatment, and pathophysiology. Neurology 2001;56:8-13.
26. Chen H, Zhang SM, Hernan MA, Willett WC, Ascherio A. Diet and Parkinson's disease: a potential role of dairy products in men. Ann Neurol 2002;52:793-801.
27. Willett WC, Sampson L, Browne ML, et al. The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol 1988;127:188-199.
28. Wolk A, Bergstrom R, Hansson LE, Nyren O. Reliability of retrospective information on diet 20 years ago and consistency of independent measures of remote adolescent diet. Nutr Cancer 1997;29:234-241.
29. Kuzma JW, Lindsted KD. Determinants of long-term (24-year) diet recall ability using a 21-item food frequency questionnaire. Nutr Cancer 1989;12:151-160.
30. Byers TE, Rosenthal RI, Marshall JR, Rzepka TF, Cummings KM, Graham S. Dietary history from the distant past: a methodological study. Nutr Cancer 1983;5:69-77.
31. Hislop TG, Lamb CW, Ng VT. Differential misclassification bias and dietary recall for the distant past using a food frequency questionnaire. Nutr Cancer 1990;13:223-233.
32. Vingerhoets FGJ, Snow BJ, Lee CS, Schulzer M, Mak E, Calne DB. Longitudinal fluorodopa positron emission tomography studies of the evolution of idiopathic parkinsonism. Ann Neurol 1994;36:759-764.
33. Morrish PK, Sawke GV, Brooks DJ. An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease. Brain 1996;119:585-591.
34. Wang GJ, Volkow ND, Fowler JS. The role of dopamine in motivation for food in humans: implications for obesity. Expert Opin Ther Targets 2002;5:601-609.
35. Wang G-J, Volkow ND, Logan J, et al. Brain dopamine and obesity. Lancet 2001;357:354-357.
36. Volkow ND, Wang G-J, Fowler JS, et al. "Nonhedonic" food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect. Synapse 2002;44:175-180.